Immunotherapy for refractory B-cell acute lymphoblastic leukemia
The five-year survival rate for children and adolescents with acute lymphoblastic leukemia (ALL) has reached about 90% with chemotherapy. Clinicians increasingly are turning to immunotherapy for relapsed/refractory B-cell ALL (B-ALL). Immunotherapy harnesses the innate power [...]
View moreMultidisciplinary care for the pregnant sickle cell disease patient
Sickle cell disease (SCD) in pregnancy raises the risk to mother and baby as well as complications of SCD, but working closely with the patient’s hematologist and a maternal-fetal medicine specialist improves the chances of […]
View moreJanuary 2022 Norton Children’s Medical Group New Providers
Norton Children’s Medical Group welcomes these new providers. Amy E. DiPietro, M.D. Pediatric Cardiology Yuan Yuan Gong, M.D. Pediatric Emergency Medicine Katelyn Rossow, M.D. Pediatric Genetics and Genomics Patricia Walsh, PA-C Pediatric Urology Allison Reynolds, […]
View moreStudy recommends genome sequencing of newborns while in the neonatal intensive care unit
Seriously ill infants with a suspected genetic disorder should undergo genome sequencing (GS) as a first-line genetic test rather than the current standard of care that can take months or years to play out, researchers [...]
View moreDon’t overlook these signs and symptoms of leukemia in children
Pediatricians can help with early detection of childhood leukemia during routine visits. Even though a patient’s signs and symptoms may appear vague, mild or suggestive of more common health conditions, they shouldn’t be ignored. In […]
View moreClassifying and treating osteogenesis imperfecta
Osteogenesis imperfecta (OI) is a clinically heterogeneous, heritable disorder characterized by increased bone fragility with a predisposition to fractures, low bone mass, bone deformities and short stature. It affects an estimate 1 in 10,000 to […]
View moreGrowth, more sophisticated care mark 2021 at Norton Children’s Heart Institute
This has been a momentous year for Norton Children’s Heart Institute, affiliated with the UofL School of Medicine. We’re completing our first full year officially integrated with the former UofL Pediatrics – Cardiology practice, which […]
View moreCardiologist aims to prevent and treat acquired heart disease in children
Preventive cardiologist Amy E. DiPietro, M.D., is joining Norton Children’s Heart Institute, affiliated with the UofL School of Medicine, as part of an expanded effort to arrest and prevent acquired heart disease in children. Dr. […]
View moreDecember 2021 Norton Children’s Medical Group New Providers
Aakriti Bhargava, M.D. Pediatric Emergency Medicine Victoria Magloire, M.D. Pediatric Emergency Medicine Esper Wadih, M.D. Pediatric Emergency Medicine Jessica Stone, PA-C Pediatric Cardiothoracic Surgery Chelsea Sabelhaus, APRN Pediatric Cardiology
View moreAsymptomatic pediatric cardiomyopathy makes family history important
Pediatric cardiomyopathy is progressive and may be asymptomatic up to sudden death, making family history an important tool in deciding when to refer patients, according to a cardiologist at Norton Children’s Heart Institute, affiliated with […]
View moreDelwyn E. McOmber, M.D., joins Norton Children’s Heart Institute
Pediatric cardiologist Delwyn E. McOmber, M.D., has joined Norton Children’s Heart Institute, affiliated with the UofL School of Medicine, as part of the Pediatric HeartCare Partners integration with Norton Children’s. In addition to practicing pediatric […]
View moreReduced-toxicity myeloablative conditioning regimen effective against high-risk pediatric leukemias
A low-toxicity myeloablative conditioning regimen is safe and effective in treating high-risk leukemias, particularly myeloid disease, according to a study recently published in the journal Pediatric Blood & Cancer. Conventional myeloablative conditioning is effective at […]
View more